Šutovská Martina, Kočmálová Michaela, Pappová Lenka, Fraňová Soňa, Chyba Andrej, Kopecký Jiří, Lukavský Jaromír, Cepák Vladislav, Capek Peter
Department of Pharmacology and BioMed Martin, Jessenius Faculty of Medicine, Mala Hora 11161/4B, 036 01 Martin, Slovakia.
Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, 845 38 Bratislava, Slovakia.
Int J Biol Macromol. 2017 Oct;103:863-869. doi: 10.1016/j.ijbiomac.2017.05.014. Epub 2017 May 18.
Microalgae organisms are of interest for many biotechnology applications due to the production of a wide range of biologically active compounds. Incubation of Wollea saccata in a large scale afforded a mucilaginous, high molecular weight biopolymer composed of carbohydrate, protein and phenolic compounds. Sugar moiety was rich in hexoses (60%) and 6-deoxyhexoses (31%), while only 9% of pentoses was identified. Methylation analysis revealed about 40 types of methylated sugar derivatives, suggesting a very complex structure of Wollea biopolymer. Pharmacological studies revealed new pharmacodynamic properties of cyanobacteria biopolymer, i.e. antitussive and bronchodilatory. Biopolymer was able to suppress the cough reflex induced by chemical tussigen, but its effect was lower than that of codeine, the strongest antitussive agent. The bronchodilatory effect was similar or higher than the effect of salbutamol, a bronchodilatory drug used in a clinical practice. In pharmacological studies, there were no signs of toxicity or side effects in the animals following administration of Wollea biopolymer.
微藻生物体因能产生多种生物活性化合物而在许多生物技术应用中备受关注。大规模培养多泡沃氏藻可得到一种由碳水化合物、蛋白质和酚类化合物组成的黏液状、高分子量生物聚合物。糖部分富含己糖(60%)和6 - 脱氧己糖(31%),而仅鉴定出9%的戊糖。甲基化分析揭示了约40种甲基化糖衍生物,表明多泡沃氏藻生物聚合物的结构非常复杂。药理学研究揭示了蓝藻生物聚合物新的药效学特性,即镇咳和支气管扩张作用。生物聚合物能够抑制化学性镇咳剂诱导的咳嗽反射,但其效果低于最强镇咳剂可待因。支气管扩张作用与临床实践中使用的支气管扩张药物沙丁胺醇的作用相似或更强。在药理学研究中,给动物施用多泡沃氏藻生物聚合物后未出现毒性或副作用迹象。